While five neurosurgery patients recovered in a hospital in Oslo, Norway, something remarkable was happening inside their skulls. A tracer dye injected into their spinal fluid was creeping along tiny channels wrapped around blood vessels deep in the brain, and for the first time in any living person, MRI cameras were watching it happen. The images, published in the Proceedings of the National Academy of Sciences in late 2024 and highlighted by the National Institutes of Health in early 2025, confirmed what neuroscientists had suspected for more than a decade: the human brain has a built-in plumbing system that flushes metabolic waste, and it appears to work hardest while we sleep.
A drainage network hiding in plain sight
The discovery traces back to 2012, when University of Rochester neuroscientist Maiken Nedergaard and her team described a network of fluid-filled channels in mouse brains that acted like a waste-disposal system. They called it the “glymphatic” system, a nod to the glial cells that form its walls and the lymphatic system it mimics. A landmark 2013 paper in Science showed that when mice fell asleep, the interstitial spaces between brain cells expanded by roughly 60 percent, allowing cerebrospinal fluid to rush through and sweep away solutes, including amyloid-beta, the protein that clumps in Alzheimer’s disease. The finding was striking, but it came with a caveat: nobody had proven the same channels existed or functioned in people.
The new study, led by neuroradiologists Per Kristian Eide and Geir Ringstad at Oslo University Hospital, closed that gap. Their five patients were already scheduled for tumor-related surgery and had lumbar drains placed as part of standard care. The researchers used those drains to deliver gadolinium, a contrast agent visible on MRI, directly into the cerebrospinal fluid. Then they scanned the patients’ brains at 12, 24, and 48 hours. The resulting images showed gadolinium traveling through distinct perivascular spaces, the same type of conduits Nedergaard’s group had mapped in mice. An NIH summary of the work called it the first direct demonstration of a glymphatic-like pathway in the living human brain.
Following the fluid from brain to neck
Perivascular channels are only the first leg of the journey. Separate tracer studies from the same Oslo group have mapped where the fluid goes after it collects waste. One study showed that CSF-borne tracers reach the parasagittal dura, the tough tissue lining the top of the brain near a major venous channel called the sagittal sinus. That region is home to meningeal lymphatic vessels, a second drainage network discovered only in 2015. Another imaging study traced the fluid further, all the way to cervical lymph nodes in the neck, giving the system a concrete exit point into the body’s conventional lymphatic plumbing.
Taken together, the studies outline a continuous route: cerebrospinal fluid enters perivascular spaces around arteries, picks up metabolic debris as it moves through brain tissue, flows toward the dura at the top of the skull, and drains into lymph nodes in the neck. From there, the waste enters the bloodstream and is processed like any other cellular garbage. It is, in effect, the brain’s overnight sanitation crew, and the bulk of its shift appears to coincide with sleep.
What sleep actually does for the system
The mouse data on sleep and clearance is robust. In Nedergaard’s 2013 experiments, anesthetized or naturally sleeping mice cleared injected amyloid-beta roughly twice as fast as awake mice. The mechanism was physical: sleep widened the gaps between cells, giving fluid more room to flow. But translating that finding to humans has been slower. A small human imaging study published in Brain Research found evidence that sleep deprivation altered tracer distribution in patterns consistent with reduced clearance, though the study was too small to quantify exactly how much sleep loss it takes to meaningfully slow drainage or whether recovery sleep reverses the effect.
A newer approach may eventually answer those questions without hospital stays. Researchers described an investigational wearable device in Nature Biomedical Engineering in early 2025 that uses bioimpedance and electrophysiology sensors to track fluid shifts across a single night of sleep. The prototype correlates changes in the electrical properties of scalp tissue with sleep stages, looking for signatures that match known patterns of CSF movement. If validated at scale, the technology could let researchers study glymphatic function in thousands of people sleeping in their own beds, rather than in five patients recovering from surgery.
The large gaps that remain
For all its elegance, the evidence has real limits. The PNAS study involved five patients with brain tumors, and their surgical circumstances may have altered fluid dynamics in ways that do not reflect a healthy brain. No large-scale trial has replicated the observations in a broader or healthier population. No primary human data directly measures the clearance rate of specific harmful proteins like amyloid-beta during natural sleep. And no study has followed the same individuals over time to show that measured glymphatic impairment leads to later cognitive decline.
The connection to Alzheimer’s disease and other neurodegenerative conditions is plausible but unproven in people. It rests on animal models and indirect associations: amyloid-beta accumulates in Alzheimer’s brains, the glymphatic system clears amyloid-beta in mice, and poor sleep is epidemiologically linked to higher dementia risk. Each link in that chain is supported by published research, but the full causal sequence has not been demonstrated in a controlled human study. Researchers also do not yet know how aging, medications, chronic conditions, or individual differences in vascular anatomy and sleep architecture shape glymphatic performance over a lifetime.
Some secondary reporting has already leaped ahead of the data, suggesting that specific sleep positions, supplements, or routines can “boost” glymphatic drainage. As of June 2025, no controlled human trial has shown that any targeted intervention measurably improves waste clearance from the brain. The hypothesis is testable, by comparing pre- and post-intervention tracer dynamics in randomized trials, but those results have not been published.
Why the plumbing matters more than the hype
Strip away the speculation and what remains is still significant. For the first time, scientists have watched cerebrospinal fluid move through perivascular channels in a living human brain. They have traced that fluid from deep brain tissue to the skull lining and out through lymph nodes in the neck. And they have strong animal evidence, with growing human support, that sleep is the state in which this drainage system operates most efficiently.
None of that justifies specific medical claims about preventing dementia through better sleep habits, at least not yet. But it does something arguably more important for the long run: it gives researchers a physical system to measure, manipulate, and monitor. As larger trials enroll more diverse participants and noninvasive tools like wearable bioimpedance sensors mature, the field will be positioned to answer the questions that matter most. How much does glymphatic function vary from person to person? How strongly is it shaped by sleep quality and aging? And can anything we do about it change the trajectory of brain health over decades? The plumbing is real. The next step is figuring out how well it works, and for whom.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
